Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive celecoxib for obsessive-compulsive disorder
IRCT201512235280N21Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib in obsessive compulsive disorder (OCD), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Started May 2014; status: completed.
02
Drugs
celecoxib
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT201512235280N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201512235280N21.